Insider hears that all is not well at Nycomed.
The company(which includes the recently purchased Altana Pharma) have called all staff to a meeting next week after a recently planned "sales meeting" was cancelled.
This could be the 3rd round of restructure/redundancies in less than 2 years for the legacy Altana people.
It is rumoured that the primary care team may be axed.
No comments:
Post a Comment